| Name | Title | Contact Details |
|---|---|---|
Jordan Clothier |
Senior Assistant General Counsel | Profile |
Catharine Fortney |
Chief Compliance and Audit Officer | Profile |
Shachi Mankodi |
Senior Assistant General Counsel | Profile |
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
The Harrington Group is a Morristown, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Vigil Health Solutions Inc. is a Victoria, BC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Mission of Mercy is a community-based organization providing free healthcare and free prescription medications to the uninsured, under-insured.
The Kansas City Area Healthcare Engineers is a Kansas City, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.